Specjalistyczna Praktyka Lekarska Piotr Siergiejko
- Address
- lock Available on a paid plan
Specjalistyczna Praktyka Lekarska Piotr Siergiejko - Respiratory Medicine Research
This specialized medical practice demonstrates dedicated expertise in respiratory medicine research, with a particular focus on advancing therapeutic interventions for chronic airway diseases. The center's commitment to clinical investigation centers on evaluating innovative drug delivery systems and optimizing treatment approaches for adult patients with respiratory conditions.
- Asthma treatment and management studies
- Inhaled bronchodilator therapy evaluation
- Safety and tolerability assessments of respiratory medications
The practice has significant experience conducting clinical trials involving metered-dose inhaler (MDI) technologies, including comparative studies of different hydrofluoroalkane (HFA) propellants. Their research portfolio includes assessment of salbutamol formulations and other established respiratory therapeutics, with emphasis on long-term safety monitoring and tolerability profiles in adult asthma populations.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Specjalistyczna Praktyka Lekarska Piotr Siergiejko
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Long-Term Safety of Salbutamol Sulfate via MDI with Propellants HFA-152a and HFA-134a in Adults with Asthma | Glaxosmithkline Research & Development Limited | Phase III | Not Recruiting | Jul 2024 | Aug 2025 |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Salbutamol Sulfate | 1 | Unknown | 2024-07-01 | 2024-07-01 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.